The global Oral Medicines for Diabetes market was valued at US$ 62970 million in 2023 and is projected to reach US$ 124450 million by 2030, at a CAGR of 10.20% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Biguanides Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Oral Medicines for Diabetes include Bayer, Merck, Novartis, Huadong Medicine, Sanofi, Novo Nordisk, Servier, Takeda Pharmaceutical and Luye Pharmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Oral medications for diabetes are medications that are taken by mouth to manage blood sugar levels in people with type 2 diabetes.
This report aims to provide a comprehensive presentation of the global market for Oral Medicines for Diabetes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Medicines for Diabetes. This report contains market size and forecasts of Oral Medicines for Diabetes in global, including the following market information:
- Global Oral Medicines for Diabetes Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Oral Medicines for Diabetes Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Oral Medicines for Diabetes companies in 2023 (%)
We surveyed the Oral Medicines for Diabetes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral Medicines for Diabetes Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Oral Medicines for Diabetes Market Segment Percentages, by Type, 2023 (%)
- Biguanides
- Sulfonylureas
- Meglitinides
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
- SGLT2 Inhibitors
- Thiazolidinediones
- Alpha-Glucosidase Inhibitors
- Other
Global Oral Medicines for Diabetes Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Oral Medicines for Diabetes Market Segment Percentages, by Application, 2023 (%)
Global Oral Medicines for Diabetes Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Oral Medicines for Diabetes Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Oral Medicines for Diabetes revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Oral Medicines for Diabetes revenues share in global market, 2023 (%)
- Key companies Oral Medicines for Diabetes sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Oral Medicines for Diabetes sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Merck
- Novartis
- Huadong Medicine
- Sanofi
- Novo Nordisk
- Servier
- Takeda Pharmaceutical
- Luye Pharmaceutical
- Taiji Group
- CR Double-Crane
- AstraZeneca
- Boehringer Ingelheim
- Qilu Pharmaceutical
- Jiangsu Deyuan Pharmaceutical
- CTTQ
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Medicines for Diabetes, market overview.
Chapter 2: Global Oral Medicines for Diabetes market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Medicines for Diabetes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Medicines for Diabetes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Medicines for Diabetes capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Oral Medicines for Diabetes Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral Medicines for Diabetes Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Medicines for Diabetes Overall Market Size
2.1 Global Oral Medicines for Diabetes Market Size: 2023 VS 2030
2.2 Global Oral Medicines for Diabetes Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Oral Medicines for Diabetes Sales: 2019-2030
3 Company Landscape
3.1 Top Oral Medicines for Diabetes Players in Global Market
3.2 Top Global Oral Medicines for Diabetes Companies Ranked by Revenue
3.3 Global Oral Medicines for Diabetes Revenue by Companies
3.4 Global Oral Medicines for Diabetes Sales by Companies
3.5 Global Oral Medicines for Diabetes Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Oral Medicines for Diabetes Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Oral Medicines for Diabetes Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral Medicines for Diabetes Players in Global Market
3.8.1 List of Global Tier 1 Oral Medicines for Diabetes Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Medicines for Diabetes Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oral Medicines for Diabetes Market Size Markets, 2023 & 2030
4.1.2 Biguanides
4.1.3 Sulfonylureas
4.1.4 Meglitinides
4.1.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
4.1.6 SGLT2 Inhibitors
4.1.7 Thiazolidinediones
4.1.8 Alpha-Glucosidase Inhibitors
4.1.9 Other
4.2 By Type - Global Oral Medicines for Diabetes Revenue & Forecasts
4.2.1 By Type - Global Oral Medicines for Diabetes Revenue, 2019-2024
4.2.2 By Type - Global Oral Medicines for Diabetes Revenue, 2025-2030
4.2.3 By Type - Global Oral Medicines for Diabetes Revenue Market Share, 2019-2030
4.3 By Type - Global Oral Medicines for Diabetes Sales & Forecasts
4.3.1 By Type - Global Oral Medicines for Diabetes Sales, 2019-2024
4.3.2 By Type - Global Oral Medicines for Diabetes Sales, 2025-2030
4.3.3 By Type - Global Oral Medicines for Diabetes Sales Market Share, 2019-2030
4.4 By Type - Global Oral Medicines for Diabetes Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oral Medicines for Diabetes Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Oral Medicines for Diabetes Revenue & Forecasts
5.2.1 By Application - Global Oral Medicines for Diabetes Revenue, 2019-2024
5.2.2 By Application - Global Oral Medicines for Diabetes Revenue, 2025-2030
5.2.3 By Application - Global Oral Medicines for Diabetes Revenue Market Share, 2019-2030
5.3 By Application - Global Oral Medicines for Diabetes Sales & Forecasts
5.3.1 By Application - Global Oral Medicines for Diabetes Sales, 2019-2024
5.3.2 By Application - Global Oral Medicines for Diabetes Sales, 2025-2030
5.3.3 By Application - Global Oral Medicines for Diabetes Sales Market Share, 2019-2030
5.4 By Application - Global Oral Medicines for Diabetes Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Oral Medicines for Diabetes Market Size, 2023 & 2030
6.2 By Region - Global Oral Medicines for Diabetes Revenue & Forecasts
6.2.1 By Region - Global Oral Medicines for Diabetes Revenue, 2019-2024
6.2.2 By Region - Global Oral Medicines for Diabetes Revenue, 2025-2030
6.2.3 By Region - Global Oral Medicines for Diabetes Revenue Market Share, 2019-2030
6.3 By Region - Global Oral Medicines for Diabetes Sales & Forecasts
6.3.1 By Region - Global Oral Medicines for Diabetes Sales, 2019-2024
6.3.2 By Region - Global Oral Medicines for Diabetes Sales, 2025-2030
6.3.3 By Region - Global Oral Medicines for Diabetes Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Oral Medicines for Diabetes Revenue, 2019-2030
6.4.2 By Country - North America Oral Medicines for Diabetes Sales, 2019-2030
6.4.3 US Oral Medicines for Diabetes Market Size, 2019-2030
6.4.4 Canada Oral Medicines for Diabetes Market Size, 2019-2030
6.4.5 Mexico Oral Medicines for Diabetes Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Oral Medicines for Diabetes Revenue, 2019-2030
6.5.2 By Country - Europe Oral Medicines for Diabetes Sales, 2019-2030
6.5.3 Germany Oral Medicines for Diabetes Market Size, 2019-2030
6.5.4 France Oral Medicines for Diabetes Market Size, 2019-2030
6.5.5 U.K. Oral Medicines for Diabetes Market Size, 2019-2030
6.5.6 Italy Oral Medicines for Diabetes Market Size, 2019-2030
6.5.7 Russia Oral Medicines for Diabetes Market Size, 2019-2030
6.5.8 Nordic Countries Oral Medicines for Diabetes Market Size, 2019-2030
6.5.9 Benelux Oral Medicines for Diabetes Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Oral Medicines for Diabetes Revenue, 2019-2030
6.6.2 By Region - Asia Oral Medicines for Diabetes Sales, 2019-2030
6.6.3 China Oral Medicines for Diabetes Market Size, 2019-2030
6.6.4 Japan Oral Medicines for Diabetes Market Size, 2019-2030
6.6.5 South Korea Oral Medicines for Diabetes Market Size, 2019-2030
6.6.6 Southeast Asia Oral Medicines for Diabetes Market Size, 2019-2030
6.6.7 India Oral Medicines for Diabetes Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Oral Medicines for Diabetes Revenue, 2019-2030
6.7.2 By Country - South America Oral Medicines for Diabetes Sales, 2019-2030
6.7.3 Brazil Oral Medicines for Diabetes Market Size, 2019-2030
6.7.4 Argentina Oral Medicines for Diabetes Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Medicines for Diabetes Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Oral Medicines for Diabetes Sales, 2019-2030
6.8.3 Turkey Oral Medicines for Diabetes Market Size, 2019-2030
6.8.4 Israel Oral Medicines for Diabetes Market Size, 2019-2030
6.8.5 Saudi Arabia Oral Medicines for Diabetes Market Size, 2019-2030
6.8.6 UAE Oral Medicines for Diabetes Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Company Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Oral Medicines for Diabetes Major Product Offerings
7.1.4 Bayer Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.1.5 Bayer Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Oral Medicines for Diabetes Major Product Offerings
7.2.4 Merck Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Oral Medicines for Diabetes Major Product Offerings
7.3.4 Novartis Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.3.5 Novartis Key News & Latest Developments
7.4 Huadong Medicine
7.4.1 Huadong Medicine Company Summary
7.4.2 Huadong Medicine Business Overview
7.4.3 Huadong Medicine Oral Medicines for Diabetes Major Product Offerings
7.4.4 Huadong Medicine Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.4.5 Huadong Medicine Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Oral Medicines for Diabetes Major Product Offerings
7.5.4 Sanofi Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.5.5 Sanofi Key News & Latest Developments
7.6 Novo Nordisk
7.6.1 Novo Nordisk Company Summary
7.6.2 Novo Nordisk Business Overview
7.6.3 Novo Nordisk Oral Medicines for Diabetes Major Product Offerings
7.6.4 Novo Nordisk Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.6.5 Novo Nordisk Key News & Latest Developments
7.7 Servier
7.7.1 Servier Company Summary
7.7.2 Servier Business Overview
7.7.3 Servier Oral Medicines for Diabetes Major Product Offerings
7.7.4 Servier Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.7.5 Servier Key News & Latest Developments
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Company Summary
7.8.2 Takeda Pharmaceutical Business Overview
7.8.3 Takeda Pharmaceutical Oral Medicines for Diabetes Major Product Offerings
7.8.4 Takeda Pharmaceutical Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.8.5 Takeda Pharmaceutical Key News & Latest Developments
7.9 Luye Pharmaceutical
7.9.1 Luye Pharmaceutical Company Summary
7.9.2 Luye Pharmaceutical Business Overview
7.9.3 Luye Pharmaceutical Oral Medicines for Diabetes Major Product Offerings
7.9.4 Luye Pharmaceutical Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.9.5 Luye Pharmaceutical Key News & Latest Developments
7.10 Taiji Group
7.10.1 Taiji Group Company Summary
7.10.2 Taiji Group Business Overview
7.10.3 Taiji Group Oral Medicines for Diabetes Major Product Offerings
7.10.4 Taiji Group Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.10.5 Taiji Group Key News & Latest Developments
7.11 CR Double-Crane
7.11.1 CR Double-Crane Company Summary
7.11.2 CR Double-Crane Oral Medicines for Diabetes Business Overview
7.11.3 CR Double-Crane Oral Medicines for Diabetes Major Product Offerings
7.11.4 CR Double-Crane Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.11.5 CR Double-Crane Key News & Latest Developments
7.12 AstraZeneca
7.12.1 AstraZeneca Company Summary
7.12.2 AstraZeneca Oral Medicines for Diabetes Business Overview
7.12.3 AstraZeneca Oral Medicines for Diabetes Major Product Offerings
7.12.4 AstraZeneca Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.12.5 AstraZeneca Key News & Latest Developments
7.13 Boehringer Ingelheim
7.13.1 Boehringer Ingelheim Company Summary
7.13.2 Boehringer Ingelheim Oral Medicines for Diabetes Business Overview
7.13.3 Boehringer Ingelheim Oral Medicines for Diabetes Major Product Offerings
7.13.4 Boehringer Ingelheim Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.13.5 Boehringer Ingelheim Key News & Latest Developments
7.14 Qilu Pharmaceutical
7.14.1 Qilu Pharmaceutical Company Summary
7.14.2 Qilu Pharmaceutical Business Overview
7.14.3 Qilu Pharmaceutical Oral Medicines for Diabetes Major Product Offerings
7.14.4 Qilu Pharmaceutical Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.14.5 Qilu Pharmaceutical Key News & Latest Developments
7.15 Jiangsu Deyuan Pharmaceutical
7.15.1 Jiangsu Deyuan Pharmaceutical Company Summary
7.15.2 Jiangsu Deyuan Pharmaceutical Business Overview
7.15.3 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Major Product Offerings
7.15.4 Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.15.5 Jiangsu Deyuan Pharmaceutical Key News & Latest Developments
7.16 CTTQ
7.16.1 CTTQ Company Summary
7.16.2 CTTQ Business Overview
7.16.3 CTTQ Oral Medicines for Diabetes Major Product Offerings
7.16.4 CTTQ Oral Medicines for Diabetes Sales and Revenue in Global (2019-2024)
7.16.5 CTTQ Key News & Latest Developments
8 Global Oral Medicines for Diabetes Production Capacity, Analysis
8.1 Global Oral Medicines for Diabetes Production Capacity, 2019-2030
8.2 Oral Medicines for Diabetes Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Medicines for Diabetes Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Medicines for Diabetes Supply Chain Analysis
10.1 Oral Medicines for Diabetes Industry Value Chain
10.2 Oral Medicines for Diabetes Upstream Market
10.3 Oral Medicines for Diabetes Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Medicines for Diabetes Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Oral Medicines for Diabetes in Global Market
Table 2. Top Oral Medicines for Diabetes Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Oral Medicines for Diabetes Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Oral Medicines for Diabetes Revenue Share by Companies, 2019-2024
Table 5. Global Oral Medicines for Diabetes Sales by Companies, (K Units), 2019-2024
Table 6. Global Oral Medicines for Diabetes Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Oral Medicines for Diabetes Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Oral Medicines for Diabetes Product Type
Table 9. List of Global Tier 1 Oral Medicines for Diabetes Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Medicines for Diabetes Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Oral Medicines for Diabetes Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Oral Medicines for Diabetes Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Oral Medicines for Diabetes Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Oral Medicines for Diabetes Sales (K Units), 2019-2024
Table 15. By Type - Global Oral Medicines for Diabetes Sales (K Units), 2025-2030
Table 16. By Application ? Global Oral Medicines for Diabetes Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Oral Medicines for Diabetes Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Oral Medicines for Diabetes Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Oral Medicines for Diabetes Sales (K Units), 2019-2024
Table 20. By Application - Global Oral Medicines for Diabetes Sales (K Units), 2025-2030
Table 21. By Region ? Global Oral Medicines for Diabetes Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Oral Medicines for Diabetes Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Oral Medicines for Diabetes Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Oral Medicines for Diabetes Sales (K Units), 2019-2024
Table 25. By Region - Global Oral Medicines for Diabetes Sales (K Units), 2025-2030
Table 26. By Country - North America Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Oral Medicines for Diabetes Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Oral Medicines for Diabetes Sales, (K Units), 2019-2024
Table 29. By Country - North America Oral Medicines for Diabetes Sales, (K Units), 2025-2030
Table 30. By Country - Europe Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Oral Medicines for Diabetes Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Oral Medicines for Diabetes Sales, (K Units), 2019-2024
Table 33. By Country - Europe Oral Medicines for Diabetes Sales, (K Units), 2025-2030
Table 34. By Region - Asia Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Oral Medicines for Diabetes Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Oral Medicines for Diabetes Sales, (K Units), 2019-2024
Table 37. By Region - Asia Oral Medicines for Diabetes Sales, (K Units), 2025-2030
Table 38. By Country - South America Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Oral Medicines for Diabetes Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Oral Medicines for Diabetes Sales, (K Units), 2019-2024
Table 41. By Country - South America Oral Medicines for Diabetes Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Oral Medicines for Diabetes Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Oral Medicines for Diabetes Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Oral Medicines for Diabetes Sales, (K Units), 2025-2030
Table 46. Bayer Company Summary
Table 47. Bayer Oral Medicines for Diabetes Product Offerings
Table 48. Bayer Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Bayer Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Oral Medicines for Diabetes Product Offerings
Table 52. Merck Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Merck Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Oral Medicines for Diabetes Product Offerings
Table 56. Novartis Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Novartis Key News & Latest Developments
Table 58. Huadong Medicine Company Summary
Table 59. Huadong Medicine Oral Medicines for Diabetes Product Offerings
Table 60. Huadong Medicine Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Huadong Medicine Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Oral Medicines for Diabetes Product Offerings
Table 64. Sanofi Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. Novo Nordisk Company Summary
Table 67. Novo Nordisk Oral Medicines for Diabetes Product Offerings
Table 68. Novo Nordisk Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Novo Nordisk Key News & Latest Developments
Table 70. Servier Company Summary
Table 71. Servier Oral Medicines for Diabetes Product Offerings
Table 72. Servier Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Servier Key News & Latest Developments
Table 74. Takeda Pharmaceutical Company Summary
Table 75. Takeda Pharmaceutical Oral Medicines for Diabetes Product Offerings
Table 76. Takeda Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Takeda Pharmaceutical Key News & Latest Developments
Table 78. Luye Pharmaceutical Company Summary
Table 79. Luye Pharmaceutical Oral Medicines for Diabetes Product Offerings
Table 80. Luye Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Luye Pharmaceutical Key News & Latest Developments
Table 82. Taiji Group Company Summary
Table 83. Taiji Group Oral Medicines for Diabetes Product Offerings
Table 84. Taiji Group Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Taiji Group Key News & Latest Developments
Table 86. CR Double-Crane Company Summary
Table 87. CR Double-Crane Oral Medicines for Diabetes Product Offerings
Table 88. CR Double-Crane Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. CR Double-Crane Key News & Latest Developments
Table 90. AstraZeneca Company Summary
Table 91. AstraZeneca Oral Medicines for Diabetes Product Offerings
Table 92. AstraZeneca Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. AstraZeneca Key News & Latest Developments
Table 94. Boehringer Ingelheim Company Summary
Table 95. Boehringer Ingelheim Oral Medicines for Diabetes Product Offerings
Table 96. Boehringer Ingelheim Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Boehringer Ingelheim Key News & Latest Developments
Table 98. Qilu Pharmaceutical Company Summary
Table 99. Qilu Pharmaceutical Oral Medicines for Diabetes Product Offerings
Table 100. Qilu Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Qilu Pharmaceutical Key News & Latest Developments
Table 102. Jiangsu Deyuan Pharmaceutical Company Summary
Table 103. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Product Offerings
Table 104. Jiangsu Deyuan Pharmaceutical Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Jiangsu Deyuan Pharmaceutical Key News & Latest Developments
Table 106. CTTQ Company Summary
Table 107. CTTQ Oral Medicines for Diabetes Product Offerings
Table 108. CTTQ Oral Medicines for Diabetes Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. CTTQ Key News & Latest Developments
Table 110. Oral Medicines for Diabetes Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 111. Global Oral Medicines for Diabetes Capacity Market Share of Key Manufacturers, 2021-2024
Table 112. Global Oral Medicines for Diabetes Production by Region, 2019-2024 (K Units)
Table 113. Global Oral Medicines for Diabetes Production by Region, 2025-2030 (K Units)
Table 114. Oral Medicines for Diabetes Market Opportunities & Trends in Global Market
Table 115. Oral Medicines for Diabetes Market Drivers in Global Market
Table 116. Oral Medicines for Diabetes Market Restraints in Global Market
Table 117. Oral Medicines for Diabetes Raw Materials
Table 118. Oral Medicines for Diabetes Raw Materials Suppliers in Global Market
Table 119. Typical Oral Medicines for Diabetes Downstream
Table 120. Oral Medicines for Diabetes Downstream Clients in Global Market
Table 121. Oral Medicines for Diabetes Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Medicines for Diabetes Segment by Type in 2023
Figure 2. Oral Medicines for Diabetes Segment by Application in 2023
Figure 3. Global Oral Medicines for Diabetes Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Oral Medicines for Diabetes Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Oral Medicines for Diabetes Revenue, 2019-2030 (US$, Mn)
Figure 7. Oral Medicines for Diabetes Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oral Medicines for Diabetes Revenue in 2023
Figure 9. By Type - Global Oral Medicines for Diabetes Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 11. By Type - Global Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 12. By Type - Global Oral Medicines for Diabetes Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Oral Medicines for Diabetes Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 15. By Application - Global Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 16. By Application - Global Oral Medicines for Diabetes Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Oral Medicines for Diabetes Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Oral Medicines for Diabetes Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 20. By Region - Global Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 21. By Country - North America Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 22. By Country - North America Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 23. US Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 28. Germany Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 29. France Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 37. China Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 41. India Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 43. By Country - South America Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 44. Brazil Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Oral Medicines for Diabetes Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Oral Medicines for Diabetes Sales Market Share, 2019-2030
Figure 48. Turkey Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Oral Medicines for Diabetes Revenue, (US$, Mn), 2019-2030
Figure 52. Global Oral Medicines for Diabetes Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Oral Medicines for Diabetes by Region, 2023 VS 2030
Figure 54. Oral Medicines for Diabetes Industry Value Chain
Figure 55. Marketing Channels
